Molecular biology and the prolonged QT syndromes

American Journal of Medicine

Volumn 110, Issue 5, 2001, Pages 385-398

  Towbin, Jeffrey A ^a   Vatta, Matteo ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANESTHETIC AGENT; ANTIANGINA PECTORIS AGENT; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; ANTILIPEMIC AGENT; ASTEMIZOLE; BEPRIDIL; CALCIUM CHANNEL BLOCKING AGENT; CENTRAL NERVOUS SYSTEM AGENTS; CISAPRIDE; DIPHENHYDRAMINE; DISOPYRAMIDE; DIURETIC AGENT; ERYTHROMYCIN; HALOPERIDOL; ITRACONAZOLE; KETOCONAZOLE; PENTAMIDINE; PIMOZIDE; PROBUCOL; PROCAINAMIDE; PSYCHOTROPIC AGENT; QUINIDINE; SOTALOL; TERFENADINE; TRIMETHOPRIM; UNINDEXED DRUG;

AGE; CLINICAL FEATURE; DISEASE CLASSIFICATION; GENETIC ANALYSIS; GENOTYPE; HEART MUSCLE POTENTIAL; HUMAN; LONG QT SYNDROME; PHENOTYPE; PRIORITY JOURNAL; QT INTERVAL; REVIEW; SEX DIFFERENCE; TORSADE DES POINTES;

EID: 0035313235     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(00)00715-4     Document Type: Article

References (100)

1. Congenital deaf-mutism, function heart disease with prolongation of the Q-T interval and sudden death
2. Antmie cardiache rare in eta pediatrica
3. A new familial cardiac syndrome in children
4. The long QT syndrome: Prospective longitudinal study of 328 families
5. Sex differences in phenotypic manifestation and gene transmission in the Romano-Ward syndrome
6. Differences in the evolution of the electrocardiographic QT interval with age
7. Idiopathic long syndrome, progress and questions
8. Stress and sudden death. The case of the long QT syndrome
9. The long QT syndrome
10. The congenital long QT syndrome: An unusual cause of childhood seizures
11. QT-interval prolongation, paroxysmal ventricular arrhythmias, and convulsive syncope
12. An analysis of the time relations of electrocardiogram
13. Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients
14. The congenital long QT syndromes in children
15. Long QT syndrome associated with syndactyly identified in females
16. A molecular link between the sudden infant death syndrome and the long-QT syndrome
17. Surdocardiac and related syndromes in children
18. Genetical aspects of the cardioauditory syndrome of Jervell and Lange-Nielsen (congenital deafness and electrocardiographic abnormalities)
19. Congenital deafness associated with electrocardiographic abnormalities, fainting attacks and sudden death. A recessive syndrome
20. The long Q-T syndrome
21. Use-dependent effects of the class III antiarrhythmic agent NE-10064 (Azimilide) on cardiac repolarization: Block of delayed rectifier potassium and L-type calcium currents
22. Desired mechanisms of drugs for ventricular arrhythmia; class III antiarrhythmic agents
23. Chem cardioversion of atrial fibrillation with intravenous dofetilide
24. Effects of the class III antiarrhythmic drug dofetilide on ventricular monophasic action potential duration and QT interval dispersion in stable angina pectoris
25. A classification of antiarrhythmic action reassessed after a decade of new drugs
26. K activation in guinea pig ventricular myocytes
27. Proarrhythmic effects of the class III agent almokalant: Importance of infusion rate, QT dispersion, and early afterdepolarizations
28. Mechanism of the cardiotoxic actions of terfenadine
29. A potent inhibitory effect of erythromycin and other macrolide antibiotics on the mono-N-dealkylation metabolism on disopyramide with human liver microsomes
30. Cisapride-induced long QT interval
31. Inherited long QT syndromes: A paradigm for understanding arrhythmogenesis
32. Kr potassium channel
33. Diagnostic criteria for the long QT syndrome: An update
34. Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene
35. Ventricular tachyarrhythmias related to early afterdepolarizations and triggered firing: Relationship to QT interval prolongation and potential therapeutic role for calcium channel blocking agents
36. Epinephrine-induced ventricular premature complexes due to early afterdepolarizations and effects of verapamil and propranolol in a patient with congenital long QT syndrome
37. Evidence of genetic heterogeneity in Romano-Ward long QT syndrome: Analysis of 23 families
38. Evidence of genetic heterogeneity in the long QT syndrome
39. Two long QT syndrome loci map to chromosome 3 and 7 with evidence for further heterogeneity
40. Mapping of a gene for long QT syndrome to chromosome 4q25-27
41. Kr potassium channels with HERG, and is associated with cardiac arrhythmia
42. A recessive variant of the Romano-Ward long-QT syndrome
43. New mutations in the KVLQT1 potassium channel that cause long QT syndrome
44. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias
45. ks cardiac potassium current
46. ks potassium channel
47. A dominant negative isoform of the long QT syndrome 1 gene product
48. Dominant-negative KvLQT1 mutations underlie the LQT1 form of long QT syndrome
49. + channel mutations found in inherited cardiac arrhythmias
50. Ks activation through interactions with IsK
51. Mutation of the gene for IsK associated with both Jervell and Lange-Nielsen and Romano-Ward forms of long-QT syndrome
52. A family of potassium channel genes related to Eag in Drosophila and mammals
53. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
54. The long-QT syndrome
55. HERG, a human inward rectifier in the voltage-gated potassium channel family
56. +-channel dysfunction in an inherited cardiac arrhythmia
57. Novel mechanism associated with an inherited cardiac arrhythmia. Defective protein trafficking by the mutant HERG (G601S) potassium channel
58. HERG channel dysfunction in human long QT syndrome
59. Kr
60. Kr and trafficking in long QT syndrome
61. Assignment of the human heart tetrodotoxin-resistant voltage-gated Na channel α-subunit gene (SCN5A) to band 3p21
62. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome
63. Selective localization of cardiac SCN5A sodium channels in limbic regions of rat brain
64. Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel
65. Molecular mechanism for an inherited cardiac arrhythmia
66. Multiple mechanisms of sodium channel-linked long QT syndrome
67. + channel activity through interactions between alpha and beta 1 subunits
68. Effects of flecainide in patients with new SCN5A mutation. Mutation-specific therapy for long-QT syndrome?
69. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation
70. Cardiac conduction defects associated with mutations in SCN5A
71. + channel in mouse heart
72. Ks function
73. + channel mutations in Romano-Ward and Jervell and Lange-Nielsen inherited cardiac arrhythmias
74. Inner ear defects induced by null mutation of the IsK gene
75. Long QT syndrome-associated mutations in the S4-S5 linker of KVLQT1 potassium channels modify gating, and interaction with minK subunits
76. Age-gender influence on the rate-corrected QT interval and the QT-heart rate relation in families with genotypically characterized long QT syndrome
77. Electrocardiographic T-wave patterns in genetically distinct forms of the hereditary long-QT syndrome
78. A novel mutation on the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome
79. Brief report: Molecular basis of the long-QT syndrome associated with deafness
80. Homozygous deletion in KVLQTI associated with Jervell and Lange-Nielsen syndrome
81. KCNE1 mutations cause Jervell, and Lange-Nielsen syndrome
82. IsK and KVLQT1. Mutation in either of the two subunits of the slow component or the delayed rectifier potassium channel can cause Jervell and Lange-Nielsen syndrome
83. Mutations in a dominant-negative isoform correlate with phenotype in inherited cardiac arrhythmias
84. Low penetrance in the long-QT syndrome. Clinical impact
85. Influence of the genotype on the clinical course of the long-QT syndrome
86. Molecular diagnosis of the inherited long-QT syndrome in a woman who died after near-drowning
87. Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome
88. Clinical and genetic variables associated with acute arousal and nonarousal-related cardiac events among subjects with long QT syndrome
89. Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KVLQT1-related patients (LQTS1)
90. Effectiveness and limitations of β-blocker therapy the congenital long-QT syndrome
91. Permanent cardiac pacing in patients with the long QT syndrome
92. Efficacy of permanent pacing in the management of high risk patients with long QT syndrome
93. Cardiac pacing in the long QT syndrome: Review of available data and practical recommendations
94. Left cardiac sympathetic denervation in the therapy of the congenital long QT syndrome: A worldwide report
95. Management of the prolonged QT syndrome and recurrent ventricular fibrillation with an implantable cardioverter-defibrillator
96. Improved survival with an implanted defibrillator in patients with coronary disease at high risk of ventricular arrhythmias
97. + channel blockade, and to increase in heart rate
98. Genetically defined therapy of inherited long-QT syndrome
99. Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions